Insufficient scRNA-seq data for expression of HORMAD1 at single-cell level.
Insufficient scRNA-seq data for expression of HORMAD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 50% | 16.23 | 288 / 578 | 49% | 7.91 | 564 / 1155 |
spleen | 97% | 62.14 | 234 / 241 | 0% | 0 | 0 / 0 |
skin | 56% | 144.23 | 1009 / 1809 | 30% | 5.55 | 143 / 472 |
esophagus | 25% | 83.89 | 358 / 1445 | 58% | 8.58 | 107 / 183 |
tonsil | 0% | 0 | 0 / 0 | 60% | 5.58 | 27 / 45 |
uterus | 2% | 0.71 | 3 / 170 | 43% | 4.99 | 198 / 459 |
breast | 26% | 10.00 | 118 / 459 | 17% | 5.35 | 189 / 1118 |
intestine | 27% | 8.44 | 257 / 966 | 13% | 1.16 | 66 / 527 |
peripheral blood | 39% | 18.36 | 361 / 929 | 0% | 0 | 0 / 0 |
adipose | 30% | 12.73 | 356 / 1204 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 28% | 2.83 | 141 / 504 |
thymus | 11% | 4.43 | 72 / 653 | 6% | 0.43 | 38 / 605 |
stomach | 2% | 0.62 | 6 / 359 | 15% | 1.62 | 42 / 286 |
ovary | 1% | 0.23 | 1 / 180 | 8% | 0.65 | 33 / 430 |
pancreas | 2% | 0.41 | 5 / 328 | 6% | 0.45 | 11 / 178 |
prostate | 7% | 4.84 | 16 / 245 | 0% | 0.00 | 1 / 502 |
eye | 0% | 0 | 0 / 0 | 6% | 0.77 | 5 / 80 |
liver | 3% | 1.09 | 7 / 226 | 2% | 0.14 | 8 / 406 |
adrenal gland | 4% | 0.81 | 11 / 258 | 0% | 0.03 | 1 / 230 |
blood vessel | 5% | 1.43 | 62 / 1335 | 0% | 0 | 0 / 0 |
kidney | 3% | 0.74 | 3 / 89 | 1% | 0.06 | 9 / 901 |
muscle | 4% | 1.44 | 33 / 803 | 0% | 0 | 0 / 0 |
brain | 2% | 0.38 | 40 / 2642 | 0% | 0.01 | 1 / 705 |
heart | 1% | 0.23 | 7 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0001824 | Biological process | blastocyst development |
GO_0007130 | Biological process | synaptonemal complex assembly |
GO_0007283 | Biological process | spermatogenesis |
GO_0051598 | Biological process | meiotic recombination checkpoint signaling |
GO_0042138 | Biological process | meiotic DNA double-strand break formation |
GO_0048477 | Biological process | oogenesis |
GO_0051177 | Biological process | meiotic sister chromatid cohesion |
GO_0060629 | Biological process | regulation of homologous chromosome segregation |
GO_0005694 | Cellular component | chromosome |
GO_0000795 | Cellular component | synaptonemal complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | HORMAD1 |
Protein name | HORMA domain-containing protein 1 HORMA domain-containing protein 1 (Cancer/testis antigen 46) (CT46) (Newborn ovary HORMA protein) |
Synonyms | NOHMA |
Description | FUNCTION: Plays a key role in meiotic progression. Regulates 3 different functions during meiosis: ensures that sufficient numbers of processed DNA double-strand breaks (DSBs) are available for successful homology search by increasing the steady-state numbers of single-stranded DSB ends. Promotes synaptonemal-complex formation independently of its role in homology search. Plays a key role in the male mid-pachytene checkpoint and the female meiotic prophase checkpoint: required for efficient build-up of ATR activity on unsynapsed chromosome regions, a process believed to form the basis of meiotic silencing of unsynapsed chromatin (MSUC) and meiotic prophase quality control in both sexes. . |
Accessions | ENST00000368995.8 [Q86X24-4] ENST00000361824.7 [Q86X24-1] X6R751 Q86X24 ENST00000322343.11 [Q86X24-2] X6RG95 ENST00000442853.5 ENST00000368987.5 |